









Markets
/
Stocks
/
nasdaq-cnmd
/

Conmed Corp

CNMD

44.710USD

+0.760+1.73%

Close 11/11, 16:00（ET）Quotes delayed by 15 min

1.38BMarket Cap

21.60P/E TTM



Conmed Corp

44.710

+0.760+1.73%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Conmed Corp

Currency: USD Updated: 2025-11-11

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Conmed Corp's Score

Industry at a Glance

Industry Ranking

51 / 209

Overall Ranking

124 / 4608

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 6 analysts

Hold

Current Rating

54.000

Target Price

+22.87%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Conmed Corp Highlights

StrengthsRisks

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 25.02% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 18.63%.

Fairly Valued

The company’s latest PE is 21.62, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 36.52M shares, decreasing 13.64% quarter-over-quarter.

Held by HACAX

Star Investor HACAX holds 18.13K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-11

The company's current financial score is 8.54, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 337.93M, representing a year-over-year increase of 6.70%, while its net profit experienced a year-over-year increase of 94.16%.

Score

Industry at a Glance

Previous score

8.54

Change



Financials

5.69

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.60

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.25

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.14

Key Metrics

Free cash flow

No Data

Conmed Corp's Company Valuation

Currency: USD Updated: 2025-11-11

The company’s current valuation score is 8.23, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 21.62, which is 176.16% below the recent high of 59.70 and 301.44% above the recent low of -43.55.

Score

Industry at a Glance

Previous score

8.23

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 51/209

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-11

The company’s current earnings forecast score is 6.33, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Conmed Corp is 52.00, with a high of 65.00 and a low of 47.00.

Score

Industry at a Glance

Previous score

6.33

Change

Support & Resistance

No Data

Analyst Rating

Based on 6 analysts

Hold

Current Rating

54.000

Target Price

+22.87%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Conmed Corp

CNMD

Apple Inc

AAPL

Ge Vernova Inc

GEV

Tapestry Inc

TPR

FMC Corp

FMC

Avantor Inc

AVTR

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-11

The company’s current price momentum score is 6.69, which is lower than the Healthcare Equipment & Supplies industry's average of 7.18. Sideways: Currently, the stock price is trading between the resistance level at 49.02 and the support level at 41.01, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.43

Change

0.26

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.133

Sell

RSI(14)

43.319

Neutral

STOCH(KDJ)(9,3,3)

49.079

Buy

ATR(14)

1.741

High Vlolatility

CCI(14)

-48.966

Neutral

Williams %R

59.122

Sell

TRIX(12,20)

-0.241

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

44.256

Buy

MA10

44.705

Buy

MA20

45.865

Sell

MA50

47.848

Sell

MA100

50.056

Sell

MA200

54.308

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-11

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 117.92%, representing a quarter-over-quarter increase of 1.67%. The largest institutional shareholder is The Vanguard, holding a total of 3.60M shares, representing 11.63% of shares outstanding, with 0.68% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

4.43M

-2.92%

The Vanguard Group, Inc.

Star Investors

3.54M

+1.21%

EARNEST Partners, LLC

2.83M

+1.08%

Fuller & Thaler Asset Management Inc.

1.74M

+48.26%

Capital Research Global Investors

1.68M

+0.16%

Managed Account Advisors LLC

1.38M

+8.11%

State Street Investment Management (US)

1.29M

-0.68%

Westwood Management Corp. (Texas)

1.24M

-0.04%

Dimensional Fund Advisors, L.P.

1.08M

+20.50%

Macquarie Investment Management

969.64K

+1.70%

Risk Assessment

Currency: USD Updated: 2025-11-11

The company’s current risk assessment score is 6.42, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 0.97. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.